NEW YORK (Reuters) - Johnson & Johnson said on Friday it has recalled 16,000 bottles of its Risperdal schizophrenia treatment and another 24,000 bottles of a generic formulation of the medicine due to consumer reports of odors in the products.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/xDY0H6nP9nQ/us-johnsonandjohnson-recall-idUSTRE75G52M20110617
Aerobics Cardio Allergies Alternative Anti Aging Anxiety Aromatherapy
No comments:
Post a Comment